Minerva Gonzalez-Cervantes

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC).

Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC).

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 18, 2024

Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19.

Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19.

Journal: Journal of clinical immunology

Published: March 29, 2023

MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks.

MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks.

Journal: Virologie (Montrouge, France)

Published: March 10, 2023

MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks

MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks

Journal: Virologie (Montrouge, France)

Published: March 09, 2023

Erratum: CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.

Erratum: CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.

Journal: iScience

Published: January 02, 2023

Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.

Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.

Journal: Journal of clinical immunology

Published: December 23, 2022

Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.

Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.

Journal: Nature communications

Published: May 28, 2022

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Journal: The Journal of experimental medicine

Published: April 12, 2022

Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.

Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: March 31, 2022

Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.

Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.

Journal: EBioMedicine

Published: February 22, 2022

Immunogenicity and safety of Ebola virus vaccines in healthy adults: a systematic review and network meta-analysis.

Immunogenicity and safety of Ebola virus vaccines in healthy adults: a systematic review and network meta-analysis.

Journal: Human vaccines & immunotherapeutics

Published: July 16, 2021

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.

Journal: iScience

Published: February 08, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026